A Comprehensive Review: Transdermal Drug Delivery System: A Tool For Novel Drug Delivery System
DOI:
https://doi.org/10.22270/ajdhs.v2i4.24Keywords:
Skin delivery, Transdermal drug delivery, Oral route, Sildenafil citrate, Pulmonary arterial hypertensionAbstract
In the recent decade, skin delivery (topical and transdermal) has gained an unprecedented popularity, especially due to increased incidences of chronic skin diseases, demand for targeted and patient compliant delivery and interest in life cycle management strategies among pharmaceutical companies. Transdermal drug delivery system was presented to overcome the difficulties of drug delivery especially oral route. Transdermal drug delivery refers to a means of delivering drugs through the surface of the skin for local or systemic treatment. The drug functions after absorption through the skin into the systemic circulation via capillary action at a certain rate. Transdermal patches are now widely used as cosmetic, topical and transdermal delivery systems. These patches represent a key outcome from the growth in skin science, technology and expertise developed through trial and error, clinical observation and evidence-based studies that date back to the first existing human records. A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of delivery system such as oral, topical, intravenous (i.v.), intramuscular (i.m.), etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin composition offers very effective barrier that allow only small molecule based drugs to penetrate the skin and pass through the barrier. Sildenafil citrate (SLD) is a selective cyclic guanosine monophosphate-specific phosphodiesterase type 5 inhibitor used for the oral treatment of erectile dysfunction and more recently, it has been used for the treatment of pulmonary arterial hypertension and the enhancement of uteroplacental perfusion in case of fetal growth retardation. The challenges facing the oral administration of the drug include poor bioavailability and short duration of action that requires frequent administration. The main objective of transdermal drug delivery system is to deliver drugs into systemic circulation through skin at predetermined rate with minimal inter and intrapatient variations.
Keyword: Skin delivery, Transdermal drug delivery, Oral rout, Sildenafil citrate, Pulmonary arterial hypertension
References
Sharma N. A brief review on transdermal patches. Organic & Medicinal Chem. 2018; 7(2):1-5.
Hao Y, Li W, Zhou XL, et al., J. Biomed. Nanotechnol. 2017; 13:1581-1597. https://doi.org/10.1166/jbn.2017.2474
B. Barry, J. Control Release 6 (1987) 85-88. https://doi.org/10.1016/0168-3659(87)90066-6
H. Marwah, T. Garg, A.K. Goyal, et al., Drug Deliv. 23 (2016) 564-578. https://doi.org/10.3109/10717544.2014.935532
Jain M, Jain A, Khare B, Jain DK, Khan R, Jain D. An Update on the Recent Emergence of Candida auris. Asian Journal of Dental and Health Sciences. 2022; 2(1):14-9. https://doi.org/10.22270/ajdhs.v2i1.11
Kesarwani A, Yadav AK, Singh S, Hemendra Gautam, Haribansh N Singh, et al. A review-Theoretical aspects of Transdermal Drug Delivery System. Bulletin of Pharmaceutical Research 2013; 3(2):78-89.
Sampath Kumar KP, Bhowmik D, Chiranjib B, Chandira RM. A review- Transdermal Drug Delivery System- A Novel Drug Delivery System and its market scope and opportunities. International Journal of Pharma and Bio Sciences 2010; 1(2).
Venkatraman S, Gale R. Skin adhesives and skin adhesion 1. Transdermal drug delivery systems. Biomaterials 1998; 19(13):1119-36. https://doi.org/10.1016/S0142-9612(98)00020-9
Khatri S, Dhanoriya C, Jain DK. Zika virus (ZIKV) disease: past, present and future. Journal of Drug Delivery and Therapeutics. 2018; 8(6-s):320-327. https://doi.org/10.22270/jddt.v8i6-s.2076
Mathews L, Roy A. Management of pain using transdermal patches-a review. Asian J Pharm Clin Res, 2016; 9(6):32-35. https://doi.org/10.22159/ajpcr.2016.v9i6.13775
Trommer H, Neubert RH, Skin Pharmacol Physio. 2006; 19:106-121. https://doi.org/10.1159/000091978
Yasin Z.A.M., Lbrahim F, N.N. Rashid, et al., Curr Pharm Biotechnol. 2017; 18:864-876. https://doi.org/10.2174/1389201019666171219105920
Ventrelli L, Strambini LM, Barillaro G, Adv. Healthcare Mater. 2015; 4:2606-2640. https://doi.org/10.1002/adhm.201500450
Pandey SP, Khan MA, Dhote V, Dhote K, Jain DK. Formulation development of sustained release matrix tablet containing metformin hydrochloride and study of various factors affecting dissolution rate. Sch Acad J Pharm. 2019; 8(3):57-73.
C. Kodiweera, Y. Yang, A. L. Bunge, J Pharm. Sci. 2017; 17:1131-1142. https://doi.org/10.1016/j.xphs.2017.12.011
Khatri S, Jain DK. Autism spectrum disorder (ASD): past, present and future. CIBTech Journal of Pharmaceutical Sciences. 2018; 7(4):1-25.
Cevc G, Vierl U, J Control Release 2010; 141:277-299. https://doi.org/10.1016/j.jconrel.2009.10.016
Armengot-Carbo M, Hernandez-Martin A, Torrelo A, Actas Dermosifiliogr. 2015; 106:86-95. https://doi.org/10.1016/j.ad.2013.10.019
Jain P, Nair S, Jain N, Jain DK, Jain S. Formulation and evaluation of solid dispersion of lomefloxacin hydrochloride. Int J Res Pharm Sci 2012; 3(4):604-608.
Erdo F, Hashimoto N, Karvaly G, et al., J. Control Release 2016; 233:147-161. https://doi.org/10.1016/j.jconrel.2016.05.035
Dhadwal A, Sharma DR, Pandit V, Ashawat MS, Kumar P, Cubosomes: A novel carrier for transdermal drug delivery, Journal of Drug Delivery and Therapeutics 2010; 10(1):123-130 https://doi.org/10.22270/jddt.v10i1.3814
Available at: http://painrelief.co.in/tr-ansdermal-patches/types-of-tdp/. Accessed on: 28 Aug, 2016.
Yadav V. Transdermal drug delivery system: review. Int. J Pharm Sci. Res. 2012;3(2):376-382.
Dhiman S, Thakur GS, Rehni AK. Transdermal patches: a recent approach to new drug delivery system. Int. J Pharmacy Pharm Sci. 2011; 3(5):26-34.
Sharma RK, Keleb E, Mosa EB, Aljahwi AAZ. Transdermal drug delivery system- design and evaluation. Int. J Advances Pharm Sci. 2010; 1:201-211.
Sandhu P, Bilandi A, Kataria S, Middha A. Transdermal drug delivery system (patches), applications in present scenario. Int. J Res. Pharm Chem. 2011; 1(4):1139-1151.
Patel D, Chaudhary SA, Parmar B, Bhura N. Transdermal drug delivery system: a review. The Pharm Innovation. 2012; 1(4):66-75. https://doi.org/10.31638/IJPRS.V1.I1.00018
Jalwal P, Jangra A, Dhaiya L, Sangwan Y, Saroha R. A review on transdermal patches. Pharm Res. J. 2010; 3:139-149.
Verma PRP and Iyer SS. Transdermal delivery of propranolol using mixed grades of eudragit: Design and in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2000; 26:471-6. https://doi.org/10.1081/DDC-100101257
Gautam SP, Rai JP, Billshaiya U, Jain N, Vikram P, Jain DK. Formulation and evaluation of mouth dissolving tablet of loperamide. International Journal of Pharmaceutical Sciences and Research. 2013; 4(5):1782.
Chung SJ. Future drug delivery research in south korea. J Controlled. Release. 1999; 62:73-9. https://doi.org/10.1016/S0168-3659(99)00025-5
Gordon RA and Peterson TA. Four myths about transdermal drug delivery. Drug Delivery Technology. 2003; 3:1-7.
Williams AC and Barry BW. Penetration enhancers, Advanced drug delivery reviews. 2004; 56:603-18. https://doi.org/10.1016/j.addr.2003.10.025
Karande P, Jain A, Ergun K, Kispersky V and Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery, Proceedings of the national academy of sciences of the United States of America. 2005; 102:4688-93. https://doi.org/10.1073/pnas.0501176102
Walters KA. Transdermal drug delivery systems In:Swarbick K., Boylan J.C, eds. Encyclopedia of pharmaceutical technology. New York, Marcel Dekker Inc. 1997; 253-293.
Kumar A, Transferosome: A recent approach for transdermal drug delivery, Journal of Drug Delivery and Therapeutics 2018; 8(5-s):100-104 https://doi.org/10.22270/jddt.v8i5-s.1981
Foco A, Hadziabdic J and Becic F. Transdermal drug delivery systems. Med Arch. 2004; 58: 230-4.
Rao PR and Diwan PY. Permeability studies of cellulose acetate free films for transdermal use: Influence of plasticizers. Pharm Acta Helv. 1997; 72:47-51. https://doi.org/10.1016/S0031-6865(96)00060-X
Barry Bw., The Lpp Theory of Skin Penetration Enhancement. Maturitas. 1998; 29: 165-85.
Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A, the Effect of Penetration Enhancers on Drug Delivery Through Skin: A Qsar Study. J Control Release.2004; 99: 113-25. https://doi.org/10.1016/j.jconrel.2004.06.010
Montia D, Saettone Mf, Giannaccini B, Angeli Dg, Enhancement of Transdermal Penetration of Dapiprazole Through Hairless Mouse Skin. J Control Release.1995; 33: 71-7. https://doi.org/10.1016/0168-3659(94)00079-A
Bharadwaj S, Gupta Gd, Sharma Vk. Topical Gel: A Novel Approach for Drug Delivery. J Chem. Bio. Phy. Sci. 2012; 2(2): 856-867.
Sharma N, Parashar B, Sharma S, Mahajan U. Blooming Pharma Industry With Transdermal Drug Delivery System. Indo Global J Pharm. Sci. 2012; 2(3): 262-278. https://doi.org/10.35652/IGJPS.2012.33
Darwhekar G, Jain Dk, Paditar Vk. Formulation and Evaluation of Transdermal Drug Delivery System of Clopidogrel Bisulfate. Asi. J. Pharmacy Life Sci. 2011; 1(3): 269-278.
Berner B, John Va. Pharmacokinetic Characterization of Transdermal Delivery System. J. Clin. Pharmaco. 1994; 26(2): 121-134. https://doi.org/10.2165/00003088-199426020-00005
Arunachalam A, Karthikeyan M, Kumar Vd, Prathap M, Sethuraman S, Ashutoshkumar S, Manidipa S. Transdermal Drug Delivery System: A Review. Current Pharma Res. 2010; 1(1):70-81. https://doi.org/10.33786/JCPR.2010.v01i01.015
Kumar Sr, Jain A, Nayak S. Development and Evaluation of Transdermal Patches of Colchicine. Der Pharmacia Lettre. 2012; 4(1): 330-343.
Patel, D., Sunita, A., Parmar B., Bhura N., Transdermal Drug Delivery System: A Review. The Pharma Innovation. 2012; 1(4): 66-75. https://doi.org/10.31638/IJPRS.V1.I1.00018
Nair SS, Chitosan-based transdermal drug delivery systems to overcome skin barrier functions, Journal of Drug Delivery and Therapeutics 2019; 9(1):266-270 https://doi.org/10.22270/jddt.v9i1.2180
Das, U. S., Pande K.H., an Overview of Diabetes Mellitus, World Journal of Pharmacy and Pharmaceutical Sciences. 2013; 2(1): 161-178.
Dhiman Sonia (2011) Transdermal Patches: A Recent Approch to New Drug Delivery System. International Journal of Pharmacy and Pharm 3(5).
Published
How to Cite
Issue
Section
Citations
Copyright (c) 2022 Sadab Sadab, Sarad Sahu, Shubham Patel, Rubeena Khan, Basant Khare, Bhupendra Singh Thakur, Anushree Jain, Prateek Kumar Jain
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.